France Pet Nutraceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the france pet nutraceuticals market was valued at USD 180.82 million in 2025 and is projected to grow from USD 188.87 million in 2026 to USD 261.14 million by 2031, registering a CAGR of 6.82% during 2026-2031.

This report is Segmented by Sub-Product (Milk Bioactives, Omega-3 Fatty Acids, Probiotics, Proteins and Peptides, Vitamins and Minerals, and More), by Pets (Cats, Dogs, and Other Pets), and by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets and Hypermarkets, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).

France Pet Nutraceuticals Market Trends and Insights

Pet Humanization and Preventive Wellness Spending

The market is supported by a growing emphasis on preventive pet care over occasional treatment. This trend facilitates the integration of supplements into daily wellness routines, addressing areas such as digestion, immunity, skin, coat, and mobility. The European Pet Food Industry Federation (FEDIAF) Nutritional Guidelines 2025 further promote this approach by offering species-specific nutrient recommendations in European countries such as France. These guidelines enhance formulation credibility, nutritional balance, and product development practices within the pet care industry. As a result, manufacturers can shift from general wellness claims to more precise nutritional support, boosting consumer trust and encouraging the regular use of nutraceutical products in long-term pet wellness programs.

Aging Pet Population and Chronic Condition Management

The nutraceuticals industry is experiencing growth due to increasing focus on age-related health conditions in companion animals, particularly those impacting mobility, joint function, and overall quality of life. As pets live longer, owners are more inclined to include nutritional supplements in daily care routines to promote long-term wellness and healthy aging. Products featuring omega-3 fatty acids, collagen derivatives, antioxidants, and other functional ingredients are being increasingly adopted as part of preventive health strategies. According to Virbac S.A., 90% of cats over 10 years old exhibit clinically significant joint issues, highlighting the demand for mobility-focused nutritional support in countries like France. This trend is driving sustained demand for senior-oriented pet nutraceutical products, where increasing pet longevity and greater awareness of preventive pet healthcare continue to encourage the adoption of age-specific nutritional solutions.

Limited Consumer Trust in Supplement Efficacy Claims

Ongoing challenges regarding consumer confidence in the efficacy of supplements, particularly those marketed for long-term wellness benefits rather than immediate, observable results. Pet owners often approach claims related to digestive health, immunity, mobility support, and healthy aging with caution, as the effectiveness of such products can be difficult to evaluate over short timeframes. This underscores the critical role of veterinary endorsements, scientific validation, transparent communication, and brand reputation in influencing purchasing decisions. Products lacking robust evidence or credible professional support tend to see slower adoption, especially in digital channels where consumers can easily compare competing claims. Consequently, established brands with strong scientific credibility maintain a competitive edge over newer entrants in the market.

Other drivers and restraints analyzed in the detailed report include:

1. Veterinary-Recommended Supplement Adoption
2. Premium and Functional Product Trade-Up
3. Regulatory Scrutiny on Functional Ingredient Positioning

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The France pet nutraceuticals market share for vitamins and minerals held the largest 26.6% in 2025. This segment leads due to the widespread use of vitamins and minerals in various daily wellness applications, such as immune support, healthy aging, metabolic balance, and nutritional reinforcement. Their versatility allows manufacturers to create products catering to different life stages and health conditions. Additionally, strong consumer familiarity with these ingredients simplifies product communication compared to more specialized nutraceutical components. This combination drives consistent demand across veterinary, specialty retail, and mainstream pet care channels.

Vitamins and minerals are forecast to grow at the fastest 7.3% CAGR from 2026 to 2031. This growth is driven by rising demand for targeted nutritional solutions aimed at companion animal wellness and preventive care. Manufacturers are increasingly developing formulations tailored to specific physiological needs, such as mobility, immunity, skin health, and age-related support. Vitamins and minerals also integrate seamlessly with broader nutraceutical formulations, enhancing their relevance across multiple product categories. Their established scientific backing, regulatory acceptance, and suitability for routine supplementation position this segment for sustained growth within the market.

Complete Report Scope:

• By Sub Product
  • Milk Bioactives
  • Omega-3 Fatty Acids
  • Probiotics
  • Proteins and Peptides
  • Vitamins and Minerals
  • Other Nutraceuticals
• By Pets
  • Cats
  • Dogs
  • Other Pets
• By Distribution Channel
  • Convenience Stores
  • Online Channel
  • Specialty Stores
  • Supermarkets/Hypermarkets
  • Other Channels

List of Companies Covered in this Report:

1. Mars, Incorporated
2. Nestle S.A.
3. Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company)
4. Virbac S.A.
5. Vetoquinol S.A.
6. Archer-Daniels-Midland Company
7. Affinity Petcare, S.A. (Agrolimen S.A.)
8. Bioiberica, S.A.U. (Bioiberica Group)
9. Nutreco N.V. (SHV Holdings N.V.)
10. Alltech, Inc.
11. Beaphar B.V.
12. Dechra Pharmaceuticals Limited

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support